ABOUT THE RESEARCHER

OVERVIEW

Dr. Bourgeois’ research is focused on applying a combination of clinical epidemiology and big data analytics to evaluate the regulation and use of medications in children and assess the integrity and availability of clinical data to support evidence-based pediatric care. She has extensive experience in the analysis of national healthcare datasets and clinical trial registries, and has leveraged these to examine medication utilization patterns, the design and conduct of clinical trials in children, and the adequacy of pre-market pediatric safety and efficacy assessments in pediatric patient populations. Dr. Bourgeois is the Director of the Pediatric Therapeutics and Regulatory Science Initiative at Boston Children’s Hospital and served as an Expert Visitor at the European Medicines Agency, where she led a project analyzing the implementation of the EUs Pediatric Regulation in order to assess approaches to increase pediatric drug research and product labeling.

As the Scientific Director of the Boston Children’s Hospital Biobank, Dr. Bourgeois is developing novel approaches and informatics-based tools to integrate clinical data with biospecimens and augment our capacity to conduct research in pediatric populations, especially those with rare diseases. Her clinical training and experience are in pediatrics and pediatric emergency medicine.

BACKGROUND

Florence Bourgeois is an Associate Professor of Pediatrics at Harvard Medical School and a faculty member in the Division of Emergency Medicine and the Computational Health Informatics Program (CHIP) at Boston Children’s Hospital. Dr. Bourgeois is a graduate of Yale University and Washington University School of Medicine in St. Louis. She completed her residency training in pediatrics and fellowship in pediatric emergency medicine at Boston Children’s Hospital. She was a NRSA research fellow and obtained a Master in Public Health in clinical effectiveness at the Harvard School of Public Health.